Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Inventory (2016 - 2025)

Bioceres Crop Solutions' Inventory history spans 10 years, with the latest figure at $83.0 million for Q2 2025.

  • On a quarterly basis, Inventory fell 25.17% to $83.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $83.0 million, a 25.17% decrease, with the full-year FY2025 number at $83.0 million, down 25.17% from a year prior.
  • Inventory hit $83.0 million in Q2 2025 for Bioceres Crop Solutions, down from $110.9 million in the prior quarter.
  • Over the last five years, Inventory for BIOX hit a ceiling of $112.0 million in Q2 2023 and a floor of $8.6 million in Q4 2021.
  • Historically, Inventory has averaged $72.1 million across 5 years, with a median of $80.9 million in 2022.
  • Biggest five-year swings in Inventory: skyrocketed 101.67% in 2022 and later dropped 25.17% in 2025.
  • Tracing BIOX's Inventory over 5 years: stood at $8.6 million in 2021, then soared by 812.31% to $78.8 million in 2022, then soared by 42.19% to $112.0 million in 2023, then fell by 0.96% to $110.9 million in 2024, then fell by 25.17% to $83.0 million in 2025.
  • Business Quant data shows Inventory for BIOX at $83.0 million in Q2 2025, $110.9 million in Q2 2024, and $112.0 million in Q2 2023.